Source: Annual Congress 2004 - Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Demedts, J. Behr, R. Buhl, G. Corvasce, U. Costabel, P. N. R. Dekhuijzen, H. M. Jansen, I. Lankhorst, N. Kormoss, W. MacNee, M. Montanari, S. Petruzzelli, M. Sardina, M. Thomeer, B. Wallaert (Leuven, Belgium). IFIGENIA: effects of N-acetylcysteine (NAC) on primary end points VC and DLco. Eur Respir J 2004; 24: Suppl. 48, 4078

Member's Comments

No comment yet.

Related content which might interest you: IFIGENIA (idiopathic pulmonary fibrosis international group exploring NAC I annual): effects of N-acetylcysteine (NAC) on lung function and gas exchange in IPF pati Source: Eur Respir J 2004; 24: Suppl. 48, 668s Year: 2004 IFIGENIA-study in IPF: effects of N-acetylcysteine (NAC) on CRP, dyspnea, exercise test and HRCT Source: Eur Respir J 2004; 24: Suppl. 48, 668s Year: 2004 CAPTAIN: Effects of lung function at screening (FEV1 % predicted) as a continuous variable on treatment outcomes Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Effects of N-acetylcysteine treatment during long-term oxygen therapy (LTOT) in COPD patients. An open parallel-group study Source: Eur Respir J 2001; 18: Suppl. 33, 58s Year: 2001 The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design Source: Eur Respir J 2001; 17: 329-336 Year: 2001 Evaluation of 4 different auto-adjusting positive airway pressure (APAP) devices: a cross-over trial versus a reference APAP (418P) Source: Eur Respir J 2005; 26: Suppl. 49, 65s Year: 2005 Long-term (1-year) effects of two methods of exercise training (ET) in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010 How reliable is total lung capacity (TLC) measured during single breath (SB) diffusion capacity test (DLCO) comparing to plethysmography (PL) method in diabetic subjects with normal lung function? Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 Quality control of DL,CO instruments in global clinical trials Source: Eur Respir J 2009; 33: 828-834 Year: 2009 Four weeks of treatment with n-acetyl cysteine (NAC) (1200mg/day) reduces lung oxidative stress and improves lung function in moderate-to-severe COPD subjects Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Fixed combination of glycopyrrolate and formoterol MDI (GFF-MDI) demonstrates superior inspiratory capacity (IC) compared to tiotropium DPI (Tio) following 7 days dosing, in a randomized, double-blind, placebo-controlled phase 2b study in patients with COPD Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 N-acetylcysteine (NAC) in the complex treatment of COVID-associated pneumonia Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 Asthma control test (ACT), fractionated exhaled nitric oxide (FeNO) and forced expiratory volume in 1 second (FEV1) correlation in asthma control Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 The effect of long term treatment with erdosteine on COPD: the Equalife study Source: Eur Respir J 2003; 22: Suppl. 45, 428s Year: 2003 Indacaterol/glycopyrronium (IND/GLY) improves lung function, health status and rescue medication use vs salmeterol/fluticasone (SFC) independent of symptom response: The FLAME study Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Acute effects of tiotropium (T), salmeterol (S) and formoterol (F) on arterial blood gases (ABGs) in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 576s Year: 2005 PULSAR: A phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-011) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH) Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Bus drivers supplemented with the anti-oxidant, N-acetyl cysteine (NAC) for 4 weeks show reduced lung oxidative stress and improved lung function Source: Annual Congress 2007 - Acute and chronic effects of air pollution Year: 2007 Post-bronchodilator response (PBDR) evaluated by plethysmographic and spirometric target parameters in patients with COPD, asthma-COPD-overlap (ACO) and asthma Source: International Congress 2018 – Innovations in equipment and their application Year: 2018